Qube Research & Technologies (QRT)’s Evolent Health EVH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$5.3M	Buy	1,518,908 +1,302,733	+603%	+$5.78M	﹤0.01%	1781
2026 Q2	$1.17M	Sell	216,175 -341,655	-61%	-$1.31M	﹤0.01%	2350
2026 Q1	$1.27M	Buy	557,830 +383,802	+221%	+$1.22M	﹤0.01%	2386
2025 Q4	$696K	Buy	+174,028	New	+$967K	﹤0.01%	2704
2024 Q3	–	Sell	-638,164	Closed	-$12.2M	–	3525
2024 Q2	$12.2M	Buy	638,164 +532,474	+504%	+$13.6M	0.02%	823
2024 Q1	$3.47M	Buy	105,690 +91,123	+626%	+$2.91M	0.01%	1432
2023 Q4	$481K	Buy	+14,567	New	+$412K	﹤0.01%	2310
2022 Q4	–	Sell	-81,883	Closed	-$2.94M	–	2612
2022 Q3	$2.94M	Buy	+81,883	New	+$2.88M	0.02%	787
2022 Q2	–	Sell	-33,974	Closed	-$1.1M	–	2661
2022 Q1	$1.1M	Buy	33,974 +15,840	+87%	+$415K	0.01%	1128
2021 Q4	$502K	Buy	+18,134	New	+$520K	﹤0.01%	1566

Other funds holding EVH

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Rubicon Founders Nashville, Tennessee $147M AUM 17% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Rock Point Advisors Burlington, Vermont $402M AUM 17.12% 1-Year Est. Return

Qube Research & Technologies (QRT)'s EVH Position: Q3 2026 in Review

Qube Research & Technologies (QRT) increased its Evolent Health (EVH) stake by 603% in Q3 2026, buying an estimated $5.78M and bringing the position to 1,518,908 shares worth $5.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

Qube Research & Technologies (QRT) first reported a position in EVH in Q4 2021 and has held it in 10 quarters since. The position peaked at $12.2M in Q2 2024. 129 funds tracked by Wall St. Rank hold EVH as of Q3 2026.

Qube Research & Technologies (QRT) held 1,518,908 shares of Evolent Health worth $5.3M as of Q3 2026.
Qube Research & Technologies (QRT) bought 1,302,733 Evolent Health shares in Q3 2026, an estimated $5.78M.
Evolent Health made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #1781 holding.
Qube Research & Technologies (QRT) first reported a position in Evolent Health in Q4 2021 and has held it in 10 quarters since.
Qube Research & Technologies (QRT)'s Evolent Health position peaked at $12.2M in Q2 2024.
129 funds tracked by Wall St. Rank held Evolent Health as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.